Ozempic 3.0? Retatrutide — an experimental drug nicknamed “triple G” — could be your best shot at a slimmer waistline when it ...

This could start to bring down the cost of brand-name competitors—here's who may get to use it, and one major difference from ...

The Food and Drug Administration approved Eli Lilly’s weight-loss drug Zepbound on Dec. 27 to treat sleep apnea, a common but ...

The first medication for obstructive sleep apnea has been approved by the US Food and Drug Administration (FDA).

FDA approves Zepbound for obstructive sleep apnea in obese individuals Discover how this weight-loss drug reduces symptoms ...

The Food and Drug Administration has approved Zepbound, a GLP-1 weight-loss drug from Eli Lilly & Co ... apnea," said Dr. Sally Seymour of the FDA's Center for Drug Evaluation and Research.

Advertising Even before the FDA approval, some doctors have been prescribing weight-loss drugs to people with sleep apnea. The FDA’s decision may place added pressure on insurance companies to ...

The Food and Drug Administration on Friday approved Eli Lilly ... the condition by reducing body weight, according to the FDA. The move comes as weight-loss medications have garnered immense ...

which was approved for weight loss for those with obesity, or who are overweight and have a weight-related health condition, in November 2023. Although the new FDA green light doesn’t expand the ...

21 (UPI) --Zepbound, the new GLP-1 weight-loss ... "Today's approval marks the first drug treatment option for certain patients with obstructive sleep apnea," said Dr. Sally Seymour of the FDA's ...

The FDA said ... that by aiding weight loss, Zepbound improves sleep apnea symptoms in some patients. The weight loss drug Zepbound has become the first prescription medication approved to treat ...